CYTOMX THERAPEUTICS INC shareholders Q3 2023

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

CYTOMX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
STATE STREET CORP 267,476$345,0440.00%
Cutler Group LLC / CA 1,000$10.00%
Raleigh Capital Management Inc. 250$3230.00%
JPMORGAN CHASE & CO 1,730$2,2320.00%
COMMONWEALTH EQUITY SERVICES, LLC 53,243$690.00%
D. E. Shaw & Co., Inc. 73,494$94,8070.00%
Bollard Group LLC 712$10.00%
VANGUARD GROUP INC 4,902,943$6,324,7970.00%
Vontobel Holding Ltd. 10,000$12,9000.00%
FEDERATED HERMES, INC. 1,415$1,8250.00%
UBS Group AG 18,703$24,1270.00%
RHUMBLINE ADVISERS 1,291$1,6650.00%
PRUDENTIAL FINANCIAL INC 16,300$21,0270.00%
WHITTIER TRUST CO 6,604$8,4530.00%
BNP PARIBAS FINANCIAL MARKETS 236$3040.00%
TWO SIGMA INVESTMENTS, LP 50,092$64,6190.00%
FMR LLC 707,968$913,2780.00%
FRANKLIN RESOURCES INC 26,838$34,6210.00%
BANK OF AMERICA CORP /DE/ 25,565$32,9780.00%
Russell Investments Group, Ltd. 45,626$58,8560.00%
External links

This page lists CYTOMX THERAPEUTICS INC's shareholders in Q3 2023. To view CYTOMX THERAPEUTICS INC's shareholder history, click here.